Huang, Jing-hao
Huang, Hui-jin
Gao, Hong-xin
Lin, Liu-rong
Ling, Xin
Zhou, Qian
Lin, Xian-zhong
Article History
Received: 11 December 2024
Revised: 14 August 2025
Accepted: 23 August 2025
First Online: 15 September 2025
Declarations
:
: The authors have no relevant financial or non-financial interests to disclose.
: The trial was approved by the Ethics Committee (Branch for Medical Research and Clinical Technology Application) of the First Affiliated Hospital of Fujian Medical University (MRCTA, ECFAH of FMU [2021] 141-1). Prior to participant enrollment, the trial was prospectively registered with the Chinese Clinical Trial Registry (Registration ID: ChiCTR2300069905; Date: 29 March 2023). All procedures involving human participants were conducted in accordance with the ethical standards of the institutional and/or national research committees, as well as the 1964 Helsinki Declaration and its subsequent amendments or comparable ethical standards. Informed consent was obtained from all participants.
: All participants provided written consent for the publication of anonymized data derived from this trial. No identifiable personal information is included in any part of this manuscript, including figures and tables.